CURAS — Curasight A/S Share Price
Last trade - 00:00- DKK181.03m
- DKK160.95m
- -DKK25.73m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.77 | ||
| Price to Tang. Book | 7.63 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | -7.04 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -105.83% | ||
| Return on Equity | -58.85% | ||
| Operating Margin | 129.09% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKKm | -0.74 | 0.03 | -7.46 | -11.49 | -25.73 | n/a | 42.98 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Curasight A/S is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). The technology provides improved diagnosis and risk stratification in multiple cancer types.
Directors
- Per Falholt CHM (63)
- Ulrich Krasilnikoff CEO (54)
- Lars Trolle VCH (54)
- Andreas Kjaer CFD (58)
- Jacob Madsen CFD (49)
- Carsten Nielsen CFD (38)
- Hanne Jensen OTH
- Charlotte Vedel DRC (53)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 22nd, 2013
- Public Since
- October 8th, 2020
- No. of Employees
- 4
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 19,893,891
- Address
- Ole Maaloees Vej 3, Koebenhavn N, KOEBENHAVN, 2200
- Web
- https://www.curasight.com/
- Phone
- Contact
- Ulrich Krasilnikoff
- Auditors
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELS
Similar to CURAS
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Arcede Pharma AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
FAQ
As of Today at 07:06 UTC, shares in Curasight A/S are trading at DKK9.10. This share price information is delayed by 15 minutes.
Shares in Curasight A/S last closed at DKK9.10 and the price had moved by -34.53% over the past 365 days. In terms of relative price strength the Curasight A/S share price has underperformed the FTSE Global All Cap Index by -40.03% over the past year.
There is no consensus recommendation for this security.
Curasight A/S does not currently pay a dividend.
Curasight A/S does not currently pay a dividend.
Curasight A/S does not currently pay a dividend.
To buy shares in Curasight A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of DKK9.10, shares in Curasight A/S had a market capitalisation of DKK181.03m.
Here are the trading details for Curasight A/S:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: CURAS
Based on an overall assessment of its quality, value and momentum Curasight A/S is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Curasight A/S is DKK28.99. That is 218.55% above the last closing price of DKK9.10.
Analysts covering Curasight A/S currently have a consensus Earnings Per Share (EPS) forecast of -DKK2.80 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Curasight A/S. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -58.65%.
As of the last closing price of DKK9.10, shares in Curasight A/S were trading -46.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Curasight A/S PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at DKK9.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Curasight A/S' management team is headed by:
- Per Falholt - CHM
- Ulrich Krasilnikoff - CEO
- Lars Trolle - VCH
- Andreas Kjaer - CFD
- Jacob Madsen - CFD
- Carsten Nielsen - CFD
- Hanne Jensen - OTH
- Charlotte Vedel - DRC